MAFLD: A game changer redefining fatty liver disease for adults and children

Mohammed Eslam¹, Jacob George²

Affiliations

¹ Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia. Electronic address: mohammed.eslam@sydney.edu.au.
² Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia. Electronic address: jacob.george@sydney.edu.au.

PMID: 33453327
DOI: 10.1016/j.jhep.2021.01.004

Comment

MAFLD: A game changer redefining fatty liver disease for adults and children

Mohammed Eslam et al. J Hepatol. 2021 Apr.

. 2021 Apr;74(4):992-994.

doi: 10.1016/j.jhep.2021.01.004. Epub 2021 Jan 13.

Authors

Mohammed Eslam¹, Jacob George²

Affiliations

¹ Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia. Electronic address: mohammed.eslam@sydney.edu.au.
² Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia. Electronic address: jacob.george@sydney.edu.au.

PMID: 33453327
DOI: 10.1016/j.jhep.2021.01.004

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.

Comment on

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.
Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour JF, Schattenberg JM, Kawaguchi T, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-Järvinen H, Fan JG, Grønbæk H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng MH, Fouad Y, Chan WK, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, Ratziu V, George J. Eslam M, et al. J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8. J Hepatol. 2020. PMID: 32278004 Review.
Is the name 'NAFLD' too big to fail? Let's keep it for 'nutrition-associated fatty liver disease'.
Baffy G. Baffy G. J Hepatol. 2021 Apr;74(4):988. doi: 10.1016/j.jhep.2020.11.011. Epub 2020 Dec 16. J Hepatol. 2021. PMID: 33340579 No abstract available.
Clinical utility of the MAFLD definition.
Zheng KI, Sun DQ, Jin Y, Zhu PW, Zheng MH. Zheng KI, et al. J Hepatol. 2021 Apr;74(4):989-991. doi: 10.1016/j.jhep.2020.12.016. Epub 2020 Dec 24. J Hepatol. 2021. PMID: 33347953 No abstract available.
NAFLD to MAFLD in adults but the saga continues in children: an opportunity to advocate change.
Hegarty R, Singh S, Bansal S, Fitzpatrick E, Dhawan A. Hegarty R, et al. J Hepatol. 2021 Apr;74(4):991-992. doi: 10.1016/j.jhep.2020.12.032. Epub 2021 Jan 23. J Hepatol. 2021. PMID: 33493527 No abstract available.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

MAFLD: A game changer redefining fatty liver disease for adults and children

Affiliations

MAFLD: A game changer redefining fatty liver disease for adults and children

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical